Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR18034 for Injection in Post-hemorrhoidectomy Pain
CTR20221164Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- May 2022
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal ropivacaine in postoperative pain, sponsored by Hengrui Therapeutics. Started May 2022; status: completed.
02
Drugs
liposomal ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20221164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221164.